MoU-Signing-(2)

WFH and CLAHT Group sign MoU

The World Federation of Hemophilia (WFH) is pleased to announce that it has signed a memorandum of understanding (MoU) with the Grupo Cooperativo Latinoamericano de Hemostasia y Trombosis (the CLAHT Group) to collaborate on the improvement of care for the bleeding disorders community in Latin America. The WFH works with organizations around the world to make sustainable care possible for bleeding disorders communities. This MoU is the culmination of years of productive collaboration between the two organizations.

Also available in: Français Español

“Our two organizations have the common objective of promoting training and the exchange of knowledge between health professionals who are working in the field of bleeding disorders in Latin America,” says Cesar Garrido, WFH President. “This MoU solidifies the collaboration and cooperation that we are proud to say has been taking place for many years now.”

The CLAHT Group aims to promote training and the exchange of knowledge between hemostasis and thrombosis health professionals in Latin America, and foster collaboration between regional organizations in the field. As a well-established medical group comprised of hematologists and laboratory professionals in the region, the CLAHT Group has closely worked with WFH for many years—and this collaboration has resulted in the sustained improvement of education and care in the region.

“The CLAHT Group has a long history of working with other organizations to further the promotion and education of bleeding disorders in Latin America,” Raúl Izaguirre Ávila, MD, President of the CLATH Group, explains. “Our collaboration with the WFH has been steadily strengthening over the last years and we are certain that the signing of this agreement will further our relationship even more.”

The MoU establishes common goals with specific objectives for improving care in Latin America. The WFH and the CLAHT Group agree to:

In addition to the above, the WFH and the CLAHT Group will work to disseminate the WFH Guidelines for the Management of Hemophilia, 3rd edition and the ASH ISTH NHF WFH 2021 guidelines on the diagnosis and management of von Willebrand disease (VWD); jointly develop projects to promote the use of the World Bleeding Disorders Registry (WBDR) among professionals in the region; train specialists on the diagnosis and care of women and girls with bleeding disorders; and to promote the use of echography as a key tool for evaluating and monitoring joint health.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.